DarioHealth Corp (DRIO : NASDAQ)
Common Stock
Follow DRIO
DRIO
DarioHealth Corp
Performance
1 Day
+16.02%
1 Week
-20.33%
1 Month
-58.79%
YTD
-66.48%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$23.42M
52W High
$14.77
52W Low
$1.70
P/E Ratio
-
50 Day MA
$5.45
200 Day MA
$7.46
Beta
1.18
Dividend Yield
-
Performance history
DRIO returns since 2026
DarioHealth Corp has traded since Jun 2026 in our data. Its deepest fall was −73.9% (Jul 2026 to Nov 2026).
1 year / yr
—
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2026*−66.5%
* Partial year (first year of data, or year to date).
$10,000 invested in DRIO
- 2026 (start of our data)$3,352
- All-time high in our data
- $8 on Jul 22, 2026 · now −69.7%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jun 2026 to Nov 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past DRIO? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/10/2026 | $2.05 | $2.57 | $1.70 | $2.39 | $2.39 | 59,351 |
| 11/9/2026 | $2.40 | $2.40 | $1.93 | $2.06 | $2.06 | 80,982 |
| 11/6/2026 | $2.74 | $2.94 | $2.38 | $2.38 | $2.38 | 14,896 |
| 11/5/2026 | $2.95 | $2.95 | $2.69 | $2.73 | $2.73 | 70,670 |
| 11/4/2026 | $3.00 | $3.07 | $2.89 | $2.97 | $2.97 | 58,715 |
| 11/3/2026 | $2.97 | $3.09 | $2.88 | $3.00 | $3.00 | 71,591 |
| 11/2/2026 | $3.06 | $3.14 | $2.95 | $3.03 | $3.03 | 76,093 |
| 10/30/2026 | $3.03 | $3.32 | $3.00 | $3.00 | $3.00 | 55,533 |
| 10/29/2026 | $3.35 | $3.52 | $3.24 | $3.31 | $3.31 | 59,376 |
| 10/28/2026 | $3.56 | $3.76 | $3.22 | $3.41 | $3.41 | 64,979 |
Analyst Price Targets
Based on 6 analysts covering DRIO · as of Nov 11, 2026
Wall Street analysts forecast DRIO stock price to rise 332.4% over the next 12 months.
Consensus
Strong Buy4.67 / 5.00
Avg. Target
US$10.33
+332.4% Upside
Previously US$12.33 on Nov 2, 2026
Current Price
US$2.39
Last close
Analyst Breakdown (6 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DRIO's historical volatility
30-Day Vol
113.3%
Annualized
90-Day Vol
86.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$2.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$2.25 | US$1.52 – US$3.33 |
| 60 trading days | US$2.12 | US$1.22 – US$3.69 |
| 90 trading days | US$2.00 | US$1.02 – US$3.94 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About DarioHealth Corp
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Financials
- Revenue (TTM)
- $21.00M
- EBITDA
- $-29.71M
- Profit Margin
- -169.87%
- ROE (TTM)
- -59.91%
- EPS (Diluted)
- -2.28
- Book Value
- 7.50
Classification
- Sector
- Health Care
- Industry
- Health Care Technology
- Group
- Health Care Equipment & Services
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About DRIO.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| SMX | SMX (Security Matters) Public Limited Company Class A Ordinary Shares | $19.25 | +105.88% |
| PEPG | PepGen Ltd | $4.61 | +92.89% |
| TTEC | TTEC Holdings Inc | $2.40 | +72.04% |
| NNOX | Nano X Imaging Ltd | $0.37 | +59.80% |
| TANH | Tantech Holdings Ltd | $30.56 | +58.01% |
| AACG | ATA Creativity Global | $0.89 | +52.14% |
| ESLA | Estrella Immunopharma Inc. | $0.75 | +45.40% |
| MNDO | MIND CTI Ltd | $1.26 | +44.83% |
Free with a Wealth Awesome account
Keep analysing DRIO, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.